Leading GMP cell therapy CDMO I Peace, Inc. ( specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that it has successfully generated human induced ...
The urgent need for better human disease models in drug discovery is increasingly recognized, with human iPSCs playing a crucial role in developing physiologically relevant in vitro models for safer, ...
This article is based on a poster originally authored by N. Lewis, D. Cole, A. Ward, J. Trigg and N. Bevan. Researchers are increasingly using 3D models, such as organoids, to generate ...
MILPITAS, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Applied StemCell, Inc.(ASC), today announced the successful knock-in of a 50 kilobase (kb) multifunctional DNA insert into human induced pluripotent ...
Researchers across discovery and translational biomedicine recognize the critical importance of iPSCs in core applications beyond regenerative medicine. Large, global biobanks offer researchers ...
A phase 1/2 study evaluating the safety and efficacy of autologous TAC T cells in subjects with claudin 18.2+ advanced solid tumors. Early phase I study of non-viral CD19/CD22/BCMA tri-targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results